Skip to main content
. 2016 May 24;2016:6762825. doi: 10.1155/2016/6762825

Table 1.

Clinical characteristics of patients.

Characteristics Control DCM DCM1 DCM2 DCM3
Age (years) 52 ± 12 54 ± 13 58 ± 11 54 ± 13 52 ± 15
Sex (male/female) 25/20 72/28 14/8 32/13 26/7
Smoking, n (%) 10 (22.2) 24 (24.0) 2 (9.1) 13 (28.9) 9 (27.3)
BMI (Kg/m2) 25.6 ± 3.4 23.9 ± 3.8 23.4 ± 3.2 23.9 ± 3.2 24.3 ± 4.9
HR (bpm) 71 ± 10 90 ± 18 89 ± 19 87 ± 17 93 ± 19
SBP (mmHg) 122 ± 12 119 ± 15 124 ± 13 119 ± 14 116 ± 17
DBP (mmHg) 71 ± 9 76 ± 12 76 ± 9 75 ± 12 76 ± 15
TG (mmol/L) 1.57 ± 0.85 1.28 ± 0.73 1.09 ± 0.33 1.46 ± 0.95 1.16 ± 0.54
TC (mmol/L) 4.51 ± 0.98 4.19 ± 1.09 4.14 ± 1.31 4.31 ± 1.14 4.09 ± 0.86
HDL-C (mmol/L) 1.15 ± 0.29 1.06 ± 0.34 1.19 ± 0.40 1.08 ± 0.31 0.94 ± 0.30
LDL-C (mmol/L) 2.72 ± 0.80 2.70 ± 0.85 2.40 ± 0.70 2.83 ± 1.02 2.73 ± 0.62
GLU (mmol/L) 5.08 ± 0.54 4.95 ± 1.23 5.15 ± 1.55 4.80 ± 0.83 5.01 ± 1.44
Creatinine (µmol/L) 72.46 ± 18.80 100.23 ± 41.43 104.68 ± 69.54 98.84 ± 31.74 99.15 ± 27.09
CRP (mg/L) 0.87 ± 0.65 7.71 ± 8.69 6.07 ± 6.79 6.93 ± 7.99 9.87 ± 10.38
CKMB (ng/mL) 1.27 ± 0.81 2.15 ± 1.50 1.84 ± 1.18 2.15 ± 1.34 2.36 ± 1.85
TnI (ng/mL) 0.01 ± 0.01 0.06 ± 0.18 0.04 ± 0.06 0.09 ± 0.26 0.04 ± 0.04
NT-proBNP (pg/mL) 94 ± 84 5053 ± 5590 3513 ± 3074 4980 ± 6092 6179 ± 6040
LVEF (%) 65.33 ± 5.67 29.89 ± 5.94 32.41 ± 4.89 30.20 ± 5.65 27.79 ± 6.36
LVEDD (mm) 46.91 ± 3.60 65.95 ± 7.52 65.27 ± 7.35 66.09 ± 7.39 66.21 ± 7.99
Medications, n (%)
 ACEI/ARB 0 37 (37) 10 (45.4) 11 (24.4) 16 (48.5)
β-blocker 0 19 (19) 8 (36.4) 7 (15.6) 4 (12.1)
 Diuretics 0 46 (46) 11 (50) 14 (31.1) 21 (63.6)
 Digitalis 0 44 (44.0) 10 (45.4) 13 (28.9) 21 (63.6)
 Spironolactone 0 31 (31) 7 (31.8) 12 (26.7) 12 (36.4)

The data are given as the mean ± SD or number of patients. DCM: dilated cardiomyopathy; BMI: body mass index; HR: heart rate; SBP: systolic blood pressure; DBP: diastolic blood pressure; TG: total triglycerides; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; GLU: fasting glucose; CRP: C-reactive protein; NT-proBNP: N-terminal pro-brain natriuretic peptide; LVEF: left ventricular ejection fraction; LVEDD: left ventricular end-diastolic dimension; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker.

P < 0.05 versus control.